Showing 2,261 - 2,280 results of 103,406 for search '(( 2 wt decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 2261

    Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout by Alper James Alcaraz (20977320)

    Published 2025
    “…RBT were exposed from 1 to 28 days post-hatch (dph) to 0.079, 0.35, 1.5, 7.4, and 29 μg/L (28 d time weighted average measured) B[<i>a</i>]P, as well as 0.05% dimethyl sulfoxide and water only controls. …”
  2. 2262

    CC-1<sup>+</sup> immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

    Published 2015
    “…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1<sup>+</sup> oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”
  3. 2263
  4. 2264
  5. 2265
  6. 2266
  7. 2267
  8. 2268
  9. 2269
  10. 2270

    Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A<sub>1</sub> ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

    Published 2013
    “…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A<sub>1</sub> AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A<sub>1</sub> ARs. …”
  11. 2271

    <i>skn-1b</i> is not required for WT or <i>daf-2</i> longevity A-F) Survival of WT and <i>skn-1b</i> mutants in the absence and presence of <i>daf-2</i> mutation. by Nikolaos Tataridas-Pallas (10231350)

    Published 2021
    “…We conclude that <i>skn-1b</i> does not contribute to <i>daf-2</i> longevity. In a total of 15 trials (13 on OP50, 2 on HT115) bacteria we observed a slight decrease in <i>skn-1b</i> longevity compared to WT in 4 trials (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s004" target="_blank">S4</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s005" target="_blank">S5</a> Tables). …”
  12. 2272
  13. 2273
  14. 2274
  15. 2275

    SEM images (a) 5LZCM (b) 10LZCM (c) 15LZCM. by Md. Abu Daud (21485629)

    Published 2025
    “…The amount of ZrO<sub>2</sub> was varied by 5wt%, 10wt%, and 15wt% for different compositions of the composites and MnO<sub>2</sub> was varied accordingly. …”
  16. 2276
  17. 2277
  18. 2278

    Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice. by Ju Kyoung Song (324058)

    Published 2013
    “…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5<sup>−/−</sup> mice and CCR5<sup>+/+</sup> mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”
  19. 2279
  20. 2280